Emmes, ILiAD partner to conduct Phase III clinical trials of Pertussis vaccine EP News Bureau Jun 25, 2024 Veridix AI, part of Emmes Group, to provide Advantage eClinical and other platform capabilities critical to accelerate and improve…
Emmes completes third ACTT clinical trial for COVID EP News Bureau Nov 30, 2021 The ACTT-III trial assessed the efficacy and safety of interferon beta-1a plus Remdesivir compared to Remdesivir alone in…
MedGenome and Emmes launch strategic partnership focussed on advancing rare disease research EP News Bureau Nov 17, 2021 During its recognition of Rare Disease Day on 5th March, 2021, the US Food and Drug Administration (FDA) noted, patients with rare…
